Podcasts about Atrium Health

In this episode of The Cardiac Recovery Room, moderator Dr. Rawn Salenger, Chief of Cardiac Surgery at the University of Maryland St. Joseph Medical Center, USA, spoke with Drs. V. Seenu Reddy, a cardiothoracic surgeon at HCA's TriStar Cardiovascular Surgery in Nashville, TN, USA, and Kevin Lobdell, Professor and Director of Regional Cardiovascular and Thoracic Quality, Education, and Research at Atrium Health, NC, USA, about postoperative rehabilitation and readmission prevention. Chapters  00:00 Intro  01:51 Readmission Risk Factors  05:17 Discharging Patients Living Alone  07:31 Importance of Readmission Reduction  10:21 Reducing Readmissions  15:45 Postop Rehabilitation  19:36 Bringing Rehab to Patients  23:43 Behavior Modification & Engagement  25:55 Coordination of Care  26:36 Personal Engagement  They explore various factors influencing patient readmission following cardiac surgery, encompassing both medical and social determinants. A significant focus is placed on the challenges faced by patients living alone, the associated risks, and the mitigation strategies that can be implemented to support them, noting how success is higher if patients have a social structure around them. Furthermore, the conversation highlights the importance of reducing readmission rates and using remote monitoring. They also examine the survival benefits of rehabilitation and barriers of postoperative rehabilitation, including transportation. The Cardiac Recovery Room is the place to hear the conversations colleagues are having after the meetings. Each month, a new episode will be released featuring a leadership panel from the ERAS Cardiac Society.     Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Rapid advances in acute ischemic stroke care have expanded treatment windows and improved patient outcomes through thrombolysis, mechanical thrombectomy, and optimized antithrombotic strategies. This episode highlights evolving approaches to patient selection, the growing role of tenecteplase, and the importance of team-based systems of care in delivering timely, effective treatment. In this episode, Casey S. Albin, MD, FAAN, speaks with Christopher R. Leon Guerrero, MD, author of the article "Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke" in the Continuum® June 2026 Cerebrovascular Disease issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Leon Guerrero is an associate professor of neurology and the adult neurology residency program director at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, where he also serves as outpatient stroke director. Additional Resources Read the article: Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Full episode transcript available here Dr Albin: In stroke care, every minute kills nearly two million neurons. But today, we're going to unpack all the details about the latest treatments that can give those neurons back.  Dr Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast.  Dr Albin: Hello and welcome. This is Dr. Casey Albin. Today, I'm interviewing Dr. Christopher Leon-Guerrero about his article on Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke. This article appears in the April 2026 Continuum issue on cerebrovascular disease. Welcome to the podcast. I always like to start by just having you introduce yourself so our listeners know a little bit about you.  Dr Leon-Guerrero: Thanks for the introduction, Dr. Albin. Really glad to be here today. My name is Chris Leon-Guerrero. I'm a vascular neurologist at Atrium Health in Charlotte, North Carolina, at Carolinas Medical Center. I'm an associate professor in the Department of Neurology. I serve as our Neurology Residency Program Director, and I also wear the hat of an outpatient stroke director in our clinics.  Dr Albin: So, you are wearing a lot of hats and balancing a lot of things, and it's a really exciting time to be talking about this. For our listeners, we are recording this right after the launch of the American Heart Association, American Stroke Association just released their new guidelines on acute ischemic care. So, no better time to kind of dive into some of this. And really, when I think about acute ischemic stroke care, it's dramatically transformed in the last two to three decades. I mean, from lengthening time windows for IV thrombolysis to expanded thrombectomy eligibility, this is really, I think, some of the most exciting stuff in neurology. And your article did a fantastic job of distilling those rapid advancements and clarifying some of the evidence behind some of these new evolving treatment selections and imaging modalities, and it's exciting. So, let's just start with thrombolysis. Where are we now with IV thrombolytics and the time windows there?  Dr Leon-Guerrero: So, a lot has changed in the last decade, since that initial trial with NINDS, nearly thirty years ago. We're still giving intravenous thrombolysis in the traditional time window up to 4.5 hours, and really emphasizing we should be selecting patients for treatment early and quickly as possible. In most of those cases, a non-con head CT is sufficient to rule out bleeding and initiate treatment as quickly as possible. Where things have gotten really exciting is using advanced neuroimaging to help select patients beyond that traditional 4.5 hour window, and we're able to treat patients even up to twenty-four hours from symptom onset.  Dr Albin: Which is really exciting. It has really totally shifted the paradigm here. You know, I think most listeners are going to be pretty familiar with three to four and a half hours. Like, that's sort of our standard. What can you tell us about some of the advanced imaging we're using for that later selection period?  Dr Leon-Guerrero: It's around the principle of you want to be able to, uh, rescue significant salvageable tissue without a lot of core. So, this large profusion deficit and small core is really how you're trying to select out these patients. And two types of modalities are used. One is going to be MRI, and a lot of those imaging protocols, you know, are outlined in the WAKE UP trial and basically are looking for patients with DWI hyperintense lesions and FLAIR negative lesions to suggest that patients in an early time window that's treatable for thrombolysis. And then in the other category, we'll be using profusion imaging, whether that's CT profusion or MR profusion, to look for patients with large salvageable tissue.  Dr Albin: Yeah. And I think that this has been one of the things that, to me, has been really impactful is I think when WAKE UP came out, it was exciting. It was fun to sort of think about, "Hey, we're going to be able to use MRI." But MRI can be very challenging to get acutely, especially in community centers where they don't have the capabilities to get someone from the emergency department into an MRI rapidly enough to make thrombolysis decisions. So, to see some of that expand to CT profusion has been really exciting. How are you going about sort of counseling patients or thinking about their risk when you're using some of those, like, advanced imaging techniques?  Dr Leon-Guerrero: Yeah. I think it's similar to the conversations we've had with patients even within the traditional 4.5 hour window. The risk for intravenous thrombolysis is hemorrhage, and counseling patients on the, you know, the risk and benefits of hemorrhage and the potential clinical benefit of receiving thrombolytics is important. And then providing patients with that information to make an informed decision, so that they can make the best decision for their own care.  Dr Albin: Totally. And it's, again, time sensitive, but trying to give families enough information and enough time to sort of process those, especially when it's a little bit beyond the standard that we're so used to consenting for. The other big area that's really changed is that tenecteplase has become the star of the show. It's really gained momentum, so what should clinicians understand about this?  Dr Leon-Guerrero: Yeah. There's been an explosion of data over the last decade on tenecteplase supporting its use for clinical practice. You know, there was recent updates even from the neurology journal with a large meta-analysis with all of the data showing good clinical outcomes and perhaps even lower risk of bleeding. And so, I think you're seeing a lot of centers across the country switching from alteplase to tenecteplase. There's some practical advantages. So tenecteplase is a one-time bolus dose. And then biologically, it seems to have better fibrin specificity, longer half-life, which may ultimately make it a more attractive drug and may make it even more effective. But I think the practical aspects of tenecteplase are not to be understated. I think there's a lot of advantages for speed and efficiency and for centers to make that switch.  Dr Albin: Yeah. I remember when our health system made the pivot from alteplase to tenecteplase. Like any changes, that obviously created some adjustments with the new workflow. But, the fact that this could be given just as a one-time dose and not with the "we got to calculate the bolus, and now we got to get the infusion on board," like really simplified workflow. So, I think that's been pragmatically one of the nicest things we've done in stroke care. Really exciting.  Dr Leon-Guerrero: Yeah. And, you know, it's a doable thing. I think you have to be, very deliberate about it at whatever center you're at to make sure that all stakeholders are aware of that change. I think that's helpful to get everybody involved and have a lot of planning to avoid wrong dosing errors or inadvertently dosing as alteplase versus tenecteplase. But it's certainly doable, and I think in the long term, centers that have switched have been pretty satisfied with tenecteplase.  Dr Albin: And you know, initially when this came out, there really was sort of a debate about, is it gonna be 0.25? Was it gonna be 0.4? Where have we landed with that debate?  Dr Leon-Guerrero: So, I think we found the correct dose is 0.25 milligrams per kilogram is the recommended dose with a max out of 25 milligrams. There's some within the American Heart Association guidelines that were just published. They mentioned even tier dosing based on 10 kilograms, so intervals. So, that may be an easier way for centers to do it. But that cap out dose of 25 milligrams at 0.25 milligrams per kilogram, I think, is the sweet spot.  Dr Albin: Yeah. That's great, and I think that that has helped, you know, say, "This is what we're doing. There's not a debate that's happening anymore." And that really just got codified in the new ASA guidelines, so really exciting there. So, there is a lot of guidance for these patients, but I think one of the things that your article really tackled is the fact that there are some special populations, where we really still don't have a lot of guidance. And so, I think just to kind of distill those for the listeners, thinking about our pregnant patients, thinking about children, how are we approaching thrombolysis decisions in these special populations?  Dr Leon-Guerrero: These are always tough cases. For example, for pregnant women, they've often been excluded in the thrombolytic trials. But there's still evidence. You know, there's some inference based on the evidence we do have, and there's a lot of registry and case reports suggesting potential safe treatment for pregnant women. And I think when you're approaching those cases, again, it's gonna be patient-centered and really should be multidisciplinary. These are the types of cases you really need to lean on your maternal fetal medicine colleagues, your high-risk OBGYNs, your obstetricians to help with that decision-making. And I think, a multidisciplinary approach is the way to go for these cases. It's the same thing with the pediatric population. We had some data. There was one trial, randomized control trial, called TIPS trial that looked at using intravenous alteplase for acute ischemic stroke in patients under the age of 18. It had difficulty with enrollment. But I think most experts would argue that patients with pediatric stroke should be considered for intravenous thrombolysis if appropriate. Again, same thing. You want to make it a multidisciplinary approach, really getting your pediatric neurologists, your pediatricians involved early to make the best decision for the patient.  Dr Albin: Yeah. That's just really an important takeaway, just thinking about this as a multidisciplinary decision, because there are going to be other stakeholders to the patient's care who may have some different information than what we as neurologists are bringing to the approach. And obviously, our perspective really matters. But trying to work in everyone's unique vantage point of the patient really helps to make the most effective decision. When we talk about acute ischemic stroke care, I really don't think that you could do justice to the topic without pivoting to mechanical thrombectomy, which, you know, as we think about how the medical field as a whole, not just neurology, how the medical field has evolved. I mean, there's probably no bigger impact than mechanical thrombectomy has made in terms of reducing not just morbidity, but mortality from stroke. I mean both. So, thrombectomy has been around for a while, but just walk our listeners through what's the core that we for sure know that these are the patients that this works for?  Dr Leon-Guerrero: The types of patients we should be selecting for intervention are patients with large vessel occlusions. And those initial trials that were published in 2015 really demonstrated that this is a quite an effective treatment for patients with large vessel occlusion ischemic strokes in the anterior circulation. When that smattering of publications occurred in 2015, the general consensus, we should be treating all patients up to six hours from symptom onset if they do have a large vessel occlusion. And then, Dr. Albin, as you know, the, the windows continue to expand. So, we were using advanced neuroimaging with MR selection and perfusion selection based on DAWN and DEFUSE 3 trial protocols to select patients all the way out to the 24 window, and it's even expanded beyond that over the last few years.  Dr Albin: I think that when we think about trials that really, totally, changed the game, when we think about DAWN and DEFUSE 3, and we switched from that time-based window to more of that, like we talked about for thrombolysis, that tissue-based clock and, like, looking at what is salvageable and where can we make an impact on salvageable tissue, truly moved the needle in terms of just bringing this therapy for people who, you know, it's hard to get in within six hours. When we moved the needle to 24, it made a huge difference. But people were still coming in with a lot of ischemic damage already done, and they would have traditionally been excluded from being enrolled in thrombectomy trials. But that's changing too. So where are we there?  Dr Leon-Guerrero: Yeah. I think there were lessons learned from DEFUSE and DAWN that we were probably over-selecting. Perhaps too stringent. You know, we had number needed to treat in the range of two to three for good outcome based on those trials. And so, I think those were lessons learned to move forward, and we, and, and people started looking at large core infarctions. And in the last few years, we've seen a multitude of randomized control trials examining large core infarctions. These are patients with ASPECT scores all the way down to zeros. A lot of the trials relied on three to six as their score, but there was at least one large core study that looked at ASPECT scores down to zero to two, and all of these studies showing benefit.  Dr Albin: Yeah. And we've really moved into if there's some tissue to spare there, probably getting clot out really makes a big difference in impact. You know, it was really surprising to me as a neurointensivist looking at these trials, that the trials had such low rates of hemorrhage, and pretty low rates of dramatic cerebral edema after thrombectomy. I don't know that we've seen all of that in sort of real world applications, but again, we are still seeing some of these patients come in, that really would've been devastated having some amount of functional recovery regained, which is incredible. In terms of another patient population that I think gives a lot of people pause or stickiness, is those basilar artery occlusions, right? Another large vessel, but one that we've had a little bit harder of a time enrolling in trials and having well-selected trials. Where are we now on whether or not basilar artery occlusion should go to mechanical thrombectomy?  Dr Leon-Guerrero: So, a lot of excitement in this area, too. There's at least two studies that were published in the last five years that were showing benefit in doing thrombectomy for patients with basilar artery occlusion up to 24 hours, and these were patients with moderate to severe deficits with NIH Stroke Scale scores greater than 10. And then making sure that they don't have large core, so using a newer scoring algorithm on the CAT scan called PC ASPECT, so basically a posterior circulation ASPECT score, to kind of make sure that patients don't have large core infarctions that are being considered for thrombectomy. All of those things collectively in those two recent studies, the ATTENTION trial and the BAOCHI trial, I think is what ended up making those studies positive, is that we were selecting the right types of patients, uh, without large core, early core, and patients with moderate to severe deficits that made the difference from previous trials.  Dr Albin: Yeah. I think that that's so important. Those trials to me, and like how long it took to get those enrolled, really emphasized to me that there really was a selection bias. Like, we believed this worked, which made it hard to then do a trial. But I'm so glad to hear that we have the data now to support moving forward in a more rigorous way.  Dr Leon-Guerrero: You're absolutely right. I think that was some of the challenges with the initial trials. In fact, the authors had commented on that. There's a lot of difficulties with lack of clinical equipoise, or experts wanting to take these patients anyways out of clinical trial and treat them, and so that's always been an issue. And then, you know, we all remember basilar artery occlusion cases. They can be severe, devastating cases in our career, but the reality is they're not that common. So, if you look at large vessel occlusions, they only account for about 10%, and if you look at all stroke patients presenting to most centers, they represent about 1% of cases. So really hard clinical trials to do just because there's thankfully not a lot of patients walking around with basilar artery occlusions, but certainly makes for challenges when you're trying to conduct randomized controlled trials on this subset of patients.  Dr Albin: Absolutely. But we did it, and I think that, like, really if, if the listeners take nothing else, it's that the field of vascular neurology is really moving forward with evidence-based, doing very rigorously controlled clinical trials, which is, I think, is what makes this field so exciting. Finally, closing out, cause we could talk all day, but we don't have all day. You know, it seems to me that more and more we are just using dual antiplatelet therapy all the time. And maybe that is, uh, a little bit of a hyperbole, cause I don't think it's all the time, but let's walk through— when is there good evidence for dual antiplatelet therapy?  Dr Leon-Guerrero: Yeah. So, there's strong evidence for early initiation of dual antiplatelet therapy or DAPT in patients with minor stroke or high-risk TIAs, and it's been studied using both clopidogrel as an add-on to aspirin and ticagrelor. Both seem like they're viable options in patients. I think one of the key things is the duration of therapy. So, in these cases with minor stroke and high-risk TIAs, we really should be confining the treatment of early DAPT for 21 days. The risk profile changes, so the risk of recurrent stroke starts to decline with time, and that risk of hemorrhage complications increases with time. And so that sweet spot of 21 days, or even some centers will do 30 days for just practical purposes, you know, really is what we should be doing in most of those cases. Other instances where DAPT can be considered, is in patients with intracranial atherosclerosis that's symptomatic, extrapolating from the SAMMPRIS trial that in the, in the medical management arm alone, used dual antiplatelet therapy with aspirin and clopidogrel for up to 90 days. So, you'll see that as well in clinical practice. Some people will opt for a 90-day duration for those patients with symptomatic intracranial atherosclerosis and stroke.  Dr Albin: Just so I emphasize, this is not set it and forget it. You can stay on DAPT forever. It is you're going to have a definitive time course, 21 days, 90 days. We have directed instructions where we're doing more benefit than harm because of that risk of hemorrhage.  Dr Leon-Guerrero: That's correct. In most cases, we really should be confining the duration of DAPT either to 21 days or 90 days. This is a challenging clinical practice. Centers really have been making an emphasis on stroke follow-up, so making sure these patients get appropriate and timely stroke follow-up to address these issues and to make sure that DAPT is discontinued if appropriate.  Dr Albin: Yeah. I love that, and I want to pull on that a little bit because you as someone who is helping direct a stroke center– A lot of this really does rely on systems of care. When we think about early lysis decisions or mechanical thrombectomy, it's how do we get the patient to one of those capable centers as quickly as possible? And then on the back end, when you're discharging a patient, how do you make sure that they are getting follow-up, making sure that they're getting their Holter monitor if they need it? You know, all the stuff that goes into kind of figuring out, why did the stroke happen? What are some of the things that you, in your role, are really excited about, that will move the needle over the next five or 10 years?  Dr Leon-Guerrero: Yeah. I think a lot of centers are doing it just like we're doing it. It really has to be a team-based approach, and you really want to reach the patient where they are in terms of the continuum of care. And so making sure if it's the in the field that you've reached out to your EMS and first responders to make sure they understand triage protocols to get patients where they need to be, to get the acute treatments that they need for the type of stroke that they're presenting with, to the actual centers that you work at, making sure your whole team, nurses, emergency physicians, APPs that are involved in care are all aware of the stroke protocols and how we're selecting these patients, making sure that your imaging protocols are up to date, and so that it's seamless when patients come in, that we're not adding on perfusion if we should have gotten that up front– We already know, have made decisions before that patient gets there. And then thinking about the patient after that hospital stay, I think, is critical. We really want to reduce their risk of recurrence, making sure that we're leveraging transitions of care, getting those patients seen in our stroke clinics for follow-up, and then make sure we're passing that baton to the long term. All of their long-term comorbidities that may be increasing their risk of stroke are managed and reduced as best as possible.  Dr Albin: From the Continuum journal to the continuum of stroke care.  Dr Leon-Guerrero: That's right.  Dr Albin: I mean, we have it all. I think that that really is so important. I'll just close with what's one thing that is your favorite part about being a vascular neurologist?  Dr Leon-Guerrero: I think it's what attracted to me to this field. As a medical student at that time, all we had was intravenous thrombolysis, and there was so much promise. There was so much promise that there was going to be widespread advancements in acute stroke, and here we are. There's been a tremendous amount of advancements and improvements for patients. I'm really excited to see what unfolds in the next few years, and I'm really excited that we've been able to increase the number of patients we're able to treat with acute ischemic stroke. I hope that we continue to expand the time window, the inclusion criteria, all of those things that we can treat more stroke patients effectively.  Dr Albin: It is really a very exciting time to be a vascular neurologist. Again, today, I've been interviewing Dr. Christopher Leon-Guerrero about his article on Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke. This article appears in the April 2026 Continuum issue on cerebrovascular disease. Be sure to check out Continuum Audio episodes from this and other issues, and thank you again, Dr. Leon Guerrero and our listeners for joining today.  Dr Leon-Guerrero: Thanks for having me.  Dr Monteith: This is Dr. Teshamae Monteith, associate editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

In this episode, hear from Brenda Gibson, former WakeMed Hospital Board Chair and WakeMed Foundation Board Chair, as she discusses the proposed WakeMed–Atrium Health strategic combination, highlighting its importance for patient access, healthcare capacity, and future growth. For more information visit wakemed.org/wakemed-atrium-combination.

Deep Dive in DDH is a three-part limited series where experts in the field of DDH have been invited to discuss the controversies in the management of hip dysplasia. Episode 1 was published in August and discussed management of DDH in infants under 6 months of age. Episode 2 was published in January and discussed the controversies in the management of developmental hip dislocations in the operating room. For the final episode we are joined by Drs. Rachel Goldstein from Children's Hospital of Los Angeles and Steve Frick from Atrium Health in Charlotte. This episode focuses on evaluation and management of residual dysplasia including nonoperative management with bracing, surveillance, and if/when to operate. Hosted by Will Morris (Scottish Rite for Children). Music by A. A. Aalto. Referenced Publications: Gans I, Flynn JM, Sankar WN. Abduction bracing for residual acetabular dysplasia in infantile DDH. J Pediatr Orthop. 2013 Oct-Nov;33(7):714-8. doi: 10.1097/BPO.0b013e31829d5704. PMID: 23812157. Swarup I, Talwar D, Sankar WN. Part-time Abduction Bracing in Infants With Residual Acetabular Dysplasia: Does Compliance Monitoring Support a Dose-dependent Relationship? J Pediatr Orthop. 2021 Feb 1;41(2):e125-e129. doi: 10.1097/BPO.0000000000001704. PMID: 33165268. Morris WZ, Kak A, Mayfield LM, Kang MS, Jo CH, Kim HKW. Does brace treatment following closed reduction of developmental dysplasia of the hip improve acetabular coverage? Bone Joint J. 2023 Dec 1;105-B(12):1327-1332. doi: 10.1302/0301-620X.105B12.BJJ-2023-0255.R1. PMID: 38035597. Albinana J, Dolan LA, Spratt KF, Morcuende J, Meyer MD, Weinstein SL. Acetabular dysplasia after treatment for developmental dysplasia of the hip. Implications for secondary procedures. J Bone Joint Surg Br. 2004 Aug;86(6):876-86. doi: 10.1302/0301-620x.86b6.14441. PMID: 15330030. Novais EN, Pan Z, Autruong PT, Meyers ML, Chang FM. Normal Percentile Reference Curves and Correlation of Acetabular Index and Acetabular Depth Ratio in Children. J Pediatr Orthop. 2018 Mar;38(3):163-169. doi: 10.1097/BPO.0000000000000791. PMID: 27261963. Haider S, Mayfield L, Kim HK, Gill CS, Sucato DJ, Podeszwa DA, Morris WZ. The Impact of Age on Outcomes Following Secondary Reconstructive Surgery for Residual Dysplasia in DDH. J Pediatr Orthop. 2026 Jan 1;46(1):e61-e66. doi: 10.1097/BPO.0000000000003067. Epub 2025 Jul 21. PMID: 40686010; PMCID: PMC12688450. Koura T, Tetsunaga T, Yamada K, Inoue T, Okuda R, Masada Y, Tetsunaga T, Okazaki Y, Ozaki T. MRI at 5 years predicts upsloping acetabular sourcil at skeletal maturity in developmental dysplasia of the hip. Hip Int. 2026 May 6:11207000261436397. doi: 10.1177/11207000261436397. Epub ahead of print. PMID: 42093127. Sucato DJ, Brabham CE, De La Rocha A, Podeszwa DA, Karol LA. Radiographic Outcome Following Treatment of Residual Hip Dysplasia with Pemberton Versus Salter Osteotomy: Comparison of Results in Patients Followed to Skeletal Maturity. J Bone Joint Surg Am. 2025 Jan 1;107(1):46-52. doi: 10.2106/JBJS.23.01346. Epub 2024 Nov 7. Erratum in: J Bone Joint Surg Am. 2025 Aug 20;107(16):e82. doi: 10.2106/JBJS.ER.23.01346. PMID: 39509475.  

This episode breaks down what the WakeMed and Atrium Health combination means for patient care, clinical expertise, and community health across Wake County. Dr. Charles Harr, cardiovascular and thoracic surgeon and chief medical officer of WakeMed Raleigh campus and former U.S. Navy rear admiral, shares firsthand perspective on the health system merger and why it matters. Listen for insights on cardiac surgery advances, minimally invasive surgery, structural heart care, clinical research trials, and physician collaboration. Learn more and stay informed at wakemed.org/wakemed-atrium-combination.  Learn more about Charles Harr, MD, MBA 

In this episode Dr. Thad McDonald, (retired OBGYN and Chair of the WakeMed Board of Directors) explains what the strategic combination with Atrium Health means for patients and the community. He discusses how the partnership will speed development of local cancer services, preserve safety net care, and improve access to specialty services. Learn more and stay informed at https://www.wakemed.org/wakemed-atrium-combination.

This episode features Sarah Crowley, Nursing Director of WakeMed Mental Health and Well-Being (including WakeMed's Mental Health and Well-Being Hospital at Wakebrook), discussing how the WakeMed and Atrium Health strategic combination could expand access and elevate patient-centered care. Sarah explains plans to increase inpatient capacity, strengthen community mental health services, and support nursing workforce development.

Send us Fan MailLeadership in healthcare simulation doesn't always come with a title or a roadmap. One day you're an educator or clinician, and the next day you're responsible for staffing, budgets, accreditation prep, outcomes, and the long list of “Can you also…?” requests that land on a simulation program. We sit down with two leaders who have lived that reality and built thriving programs anyway: Dawn Swiderski, Associate Vice President of Simulation Services at the Carolina Simulation Center at Atrium Health (now Advocate Health), and Cheryl Camacho, Director of Simulation and Outreach at Nationwide Children's Hospital.We dig into the shift from the SSH Directors Section to the Simulation Program Leadership Section and why that change is more than a rebrand. It's a move toward inclusion for people leading without the “director” label, whether you're new to simulation, stepping into management unexpectedly, or guiding a program through influence instead of authority. Dawn and Cheryl share how they listen to member feedback and turn it into practical support that actually matches what leaders need in the moment.You'll also get a clear tour of what's available through SimConnect: quarterly webinars, section meetings, and the highly popular couch conversations where members bring burning questions like simulation ROI, accreditation, costing models, policies, staffing allocation, and how to prove value with metrics and KPIs (including examples like Power BI). We talk about the underused SimConnect library filled with templates, forms, job descriptions, and recorded sessions that help you move faster, especially if you're tired of reinventing the wheel.If you lead any part of clinical simulation education, patient safety simulation, or simulation operations, this one is built for you. Subscribe, share it with a simulation colleague, and leave a review with the leadership topic you want tackled next.Innovative SimSolutions.Your turnkey solution provider for medical simulation programs, sim centers & faculty design.

Charlotte is growing fast, and a lot of that growth is being shaped by people who don't just build projects, they build communities. One of those leaders is Todd Collins, CEO and founder of Red Hill Ventures, a Charlotte-based real estate firm and investment platform focused on innovative, community-centered development. Under Todd's leadership, Red Hill Ventures has invested in and revitalized key properties across the region—from industrial parks to commercial spaces—while keeping an eye on long-term value, economic mobility, and the future of how people live and work. He's also deeply involved in Charlotte's civic and philanthropic circles, championing opportunity, diversity, and education alongside his wife, Janelle, and partners like Atrium Health. Today we're talking with Todd about how thoughtful real estate can shape a city, what he's seeing in Charlotte's market right now, and why purpose and profit don't have to be mutually exclusive. Todd, welcome to this episode of the award-winning BrandBuilders Podcast.

In this episode, Donald Gintzig, President & CEO of WakeMed Health & Hospitals, outlines specifics about the strategic combination with Atrium Health and why it matters for access, equity, and long-term community health in Wake County. Hear about the benefits of expanded services, new facilities, investments in southeast Raleigh and more that aim to improve care for all. Visit WakeMed.org/wakemed-atrium-combination to learn more.

Drug companies often initiate good-faith inquiries of covered entities (CEs) to learn more about certain purchase patterns or volumes, but how should hospitals navigate these requests? Bibi Wishart, director of pharmacy at Atrium Health, describes what she's learned being on the receiving end of these inquiries.Why Do Good-Faith Inquiries Happen?Bibi says the recent rise in good-faith inquiries is tied in part to drug companies gaining access to more varied data sources and expressing a goal of ensuring the information they collect is in line with what they are expecting. She says a variety of different factors could trigger this type of inquiry, including new providers purchasing certain drugs, concerns about duplicate discounts, or confusion around whether a drug is being used in an inpatient or outpatient setting. Hospitals are very complicated, so responding to an inquiry often can be more about educating drug companies about how hospitals dispense drugs.How Should a Hospital Respond?If her hospital receives a communication from a drug company through its authorized official and primary contact, Bibi says she prefers to respond within one or two business days just to confirm she has received the inquiry. She says that while it may take several days or weeks to respond with the requested data, that initial response establishes a cooperative tone and ultimately might prevent escalation to a formal audit process. That also gives the 340B team time to pull in the correct departments and hospital data to provide a full response.Ways To Prevent the Need for InquiriesDue to the sheer complexity of dispensing drugs — including reconciling data feeds from third-party administrators, vendors, and electronic medical records — regular internal audits are one of the best ways to identify discrepancies before drugmakers launch inquiries about them. Bibi recommends using internal auditing to catch these issues and having clear procedures in place for how to resolve any potential errors.

Charlotte Mayor Vi Lyles announces her resignation, the state Senate votes to pause property tax assessments for a year, Wake County delays a vote on the merger of Atrium Health with WakeMed, and the PGA is back in town.

State lawmakers, the Raleigh mayor, a group that represents state employees and the state’s elected attorney general, auditor and treasurer are among those weighing in on a takeover deal between two state hospital systems. Atrium Health is in position to take control of WakeMed. WRAL state government editor Jack Hagel looks at what the deal would mean, why some officials are sounding the alarm and what the future looks like as the deal is put on pause.

Send us Fan MailDr. Matthew Saxonhouse, neonatologist at Atrium Health, joins Ben to discuss two initiatives designed to fill the gaps that traditional conferences often leave behind. The first is Neonatal Insights, a biennial meeting returning January 29-31, 2027 in Houston — both in person and virtual — where controversial topics like the new hypoglycemia guidelines, cord blood transfusions, optimal caloric targets for growing infants, and wasteful NICU practices are presented from all sides with the explicit goal of reaching a working consensus. The second is Neonatal Insider, a monthly virtual series combining physiology and current evidence on hot topics, now opening its five-year archive to subscribers. He also reflects on why education that presents competing perspectives honestly is one of the most valuable things neonatology can offer its community.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

Welcome to Chatter with BNC, Business North Carolina's weekly podcast, serving up interviews with some of the Tar Heel State's most interesting people. On today's episode, Ben Kinney speaks with Adam Sperling, Executive Director of the Truist Championship, about the return of premier professional golf to Charlotte's iconic Quail Hollow Club, May 6-10. Adam shares his winding path into the golf world — from a college internship at the 2003 PGA Championship to stints at Pebble Beach, Las Vegas, and eventually Charlotte for the 2021 Presidents Cup — and why he fell in love with the region. He breaks down what's new for this year's tournament, including three reimagined fan zones, a partnership with Atrium Health offering free water and Stanley cups, first-ever public grandstand seating on the 17th green courtesy of Hendrick Auto, and a new wayfinding app powered by CPI Security. The two also dig into what makes Charlotte's corporate community so uniquely invested in events like this, the power of golf as a community gathering, and — naturally — their shared love of Goose, Bruce Springsteen, and whether playing music on the course is still controversial.

Welcome to Chatter with BNC, Business North Carolina's weekly podcast, serving up interviews with some of the Tar Heel State's most interesting people. On today's episode, Ben Kinney speaks with Adam Sperling, Executive Director of the Truist Championship, about the return of premier professional golf to Charlotte's iconic Quail Hollow Club, May 6-10. Adam shares his winding path into the golf world — from a college internship at the 2003 PGA Championship to stints at Pebble Beach, Las Vegas, and eventually Charlotte for the 2021 Presidents Cup — and why he fell in love with the region. He breaks down what's new for this year's tournament, including three reimagined fan zones, a partnership with Atrium Health offering free water and Stanley cups, first-ever public grandstand seating on the 17th green courtesy of Hendrick Auto, and a new wayfinding app powered by CPI Security. The two also dig into what makes Charlotte's corporate community so uniquely invested in events like this, the power of golf as a community gathering, and — naturally — their shared love of Goose, Bruce Springsteen, and whether playing music on the course is still controversial.

Dr. Merritt Tuttle is both a Pediatric Intensivist and Medical Toxicologist at Brenner Children's Hospital in North Carolina associated with Atrium Health and Wake Forest Baptist Health. She completed her Pediatric Critical Care and Medical Toxicology training at the Medical College of Wisconsin.Learning Objective: By the end of this podcast, listeners should be able to discuss an evidence based and expert guided approach to the evaluation and management of the critically ill child with calcium channel blocker toxicity.References:St-Onge M, Anseeuw K, Cantrell FL et al, Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults. Crit Care Med. 2017 Mar;45(3):e306-e315.2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular CareLevine M, Curry SC, Padilla-Jones A, Ruha AM. Critical care management of verapamil and diltiazem overdose with a focus on vasopressors: a 25-year experience at a single center. Ann Emerg Med. 2013 Sep;62(3):252-8. doi: 10.1016/j.annemergmed.2013.03.018. Cole JB, Arens AM, Laes JR, Klein LR, Bangh SA, Olives TD. High dose insulin for beta-blocker and calcium channel-blocker poisoning. Am J Emerg Med. 2018 Oct;36(10):1817-1824. doi: 10.1016/j.ajem.2018.02.004. Epub 2018 Feb 6.Slamowitz A, Sweberg T, Labgold K, Nickerson T. Extracorporeal Membrane Oxygenation for Calcium Channel Blocker Intoxication: A Multicenter Retrospective Registry Review. ASAIO J. 2025 Oct 31. Poison Control: (800) 222-1222Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show.Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com.  You can also check out our website at http://www.pedscrit.com. Thank you for listening to this episode of PedsCrit!

In this episode of The Cardiac Recovery Room, moderator Dr. Daniel Engelman, Medical Director of the Cardiac Surgical Critical Care & Inpatient Services at Baystate Health, Professor of Surgery at the University of Massachusetts Chan Medical School—Baystate, and President of the ERAS Cardiac Society; and co-moderator Dr. Kevin Lobdell, Professor and Director of Regional Cardiovascular and Thoracic Quality, Education, and Research at Atrium Health spoke with Dr. Rawn Salenger, Chief of Cardiac Surgery at the University of Maryland St. Joseph Medical Center and Dr. Serdar Gunaydin, Head of Department at the University of Health Sciences in Turkey, about patient blood management.   Chapters  00:00 Intro  01:14 Transfusion as a Risk Factor  07:08 Hemoglobin Drugs  08:24 Pillars of Blood Management  09:56 Anesthesia  12:30 Transfusion Triggers  17:33 O2 Delivery, Hemoglobin Number  22:20 Non-Transfusion Patients  23:22 Anemic Level Bottom Number  25:06 Bleeding Checklist  29:41 Anemia Tolerance  They discussed independent risk factors for blood transfusion, the role of hemoglobin as a predictor for blood transfusion, and considerations related to anemic patients and hemoglobin levels. Additionally, they explored the key pillars of blood management, treating preoperative anemia, and anesthesia. They examined transfusion triggers, oxygen delivery, and the care of non-transfusion patients. Finally, they emphasized the importance of a bleeding checklist and anemia tolerance.   The Cardiac Recovery Room is the place to hear the conversations colleagues are having after the meetings. Each month, a new episode will be released featuring a leadership panel from the ERAS Cardiac Society.  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

In this episode of The Cardiac Recovery Room, moderator Dr. Daniel Engelman, Medical Director of the Cardiac Surgical Critical Care & Inpatient Services at Baystate Health, Professor of Surgery at the University of Massachusetts Chan Medical School—Baystate, and President of the ERAS Cardiac Society, spoke with Drs. Kevin Lobdell, Professor and the Director of Regional Cardiovascular and Thoracic Quality, Education, and Research at Atrium Health; Rawn Salenger, Chief of Cardiac Surgery at the University of Maryland St. Joseph Medical Center; Marjan Jahangiri, Professor of Cardiac Surgery at St. George's Hospital, University of London; and Serdar Gunaydin, Head of Department at the University of Health Sciences in Turkey, about the attitudes toward and realities of ERAS across the globe.   Chapters 00:00 Intro  01:19 ICU & Early Extubation  05:07 Acceptance of ERAS Protocols  09:38 Lead Staff Advocate for ERAS  12:59 Sternotomy Perception  14:43 QoL Data Collection  17:09 Rehabilitation  19:04 Discharged Patients & Monitoring  They discussed the intensive care unit and early extubation, highlighting differences between countries. They also covered the acceptance of the ERAS protocol and the regions that are more hesitant to implement it, as well as its application in cardiac surgery specifically. Additionally, they explored who leads the charge within the team responsible for implementing ERAS and addressed perceptions regarding sternotomy. The conversation also included improving quality of life, reducing complications, and patient-reported outcomes measures, emphasizing the importance of shared decision-making. Furthermore, they discussed rehabilitation, discharging patients, and remote monitoring.   The Cardiac Recovery Room is the place to hear the conversations colleagues are having after the meetings. Each month, a new episode will be released featuring a leadership panel from the ERAS Cardiac Society.  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

In this episode, Rick Greene, MD, FACS, Emeritus Chair of Surgery at Carolinas Medical Center and Medical Director of Cancer Data Services at Atrium Health Levine Cancer Institute, shares insights on the evolution of cancer staging, data accuracy, and accreditation. He discusses how these foundations support personalized care, reduce variation, and help clinicians and patients navigate an increasingly complex oncology landscape.

Join us for an inspiring episode featuring Callie Dobbins, RN, MSN, NEA-BC, Senior Vice President of Children's at Atrium Health. Discover how she transitioned from clinical care to leadership, emphasizing the importance of teamwork and strategic vision in healthcare. Learn valuable insights on advocating for a supportive environment for future healthcare leaders. Don't miss this impactful conversation — click to listen now!  Learn more about Callie Dobbins, RN, MSN, NEA-BC  

Гостья выпуска - Екатерина Аполинская, Research Data Coordinator в Atrium Health, бывший CEO и Head of talent acquisition в российских компаниях, которая в 45 лет выиграла грин-карту и начала карьеру в США с нуля.Мы подробно разобрали путь переезда в США в зрелом возрасте, отказ от прежнего статуса и осознанный старт с позиций для начинающих. Обсудили, как справляться с языковым шоком, зачем идти на первую неофисную работу, как использовать бесплатные и недооцененные образовательные программы и нетворкинг, каким образом закрывать гэпы в резюме и получать первый американский опыт. Поговорили о работе в банке и в системе здравоохранения, отношении к возрасту на рынке труда США, стратегическом выборе профессии и планировании карьеры на 20 лет вперед без иллюзий и спешки. Екатерина Аполинская (Kate Apolinskaia) - Research Data Coordinator в Atrium Health, ex-CEO, ex-Head of Talent Acquisition в BIOCAD, ICF-коуч, Executive MBA. В 45 лет выиграла грин-карту и переехала в США, где начала карьеру с нуля. LinkedIn: https://www.linkedin.com/in/kate-apolinskaia/Ссылки, упомянутые в выпуске:https://www.goodwill.org/locate-a-career-center/https://www.upwardlyglobal.org/https://www.wes.org/ Записаться на карьерную консультацию (резюме, LinkedIn, карьерная стратегия, поиск работы в США): https://annanaumova.com Коучинг (синдром самозванца, прокрастинация, неуверенность в себе, страхи, лень): https://annanaumova.notion.site/3f6ea5ce89694c93afb1156df3c903ab Телеграм: https://t.me/prodcastUSA Инстаграм: https://www.instagram.com/prodcast.us ТикТок: https://www.tiktok.com/@us.job⏰ Timecodes ⏰00:00 Начало4:17 Почему задумалась о релокации?8:53 Как выбирала город для переезда?14:00 С чем ты приехала? Какой был уровень английского?17:16 Первая работа в США в магазин на entry-level. Зачем?23:15 Про опыт в HR в России и США29:25 Бесплатные курсы Goodwill. Что там учат?38:10 Как получить работу в банке после курсов без знания английского?48:16 Как стать нотариусом в США?50:18 Как попала в медицинскую организацию без опыта?56:48 Платная стажировка в IT-компании за $2000 - зачем это?1:04:14 Как ты получила оффер в Atrium Health?1:11:47 Как совмещаешь две позиции?1:17:14 Твоя цель - стать Project Manager. Почему именно эта роль?1:22:24 Отношение к возрасту в США vs Россия. Есть ли эйджизм?1:29:55 Какие 3 главных совета ты дашь тем, кто думает иммигрировать после 40-45 лет?

Is my CPAP helping me?Have you wondered if your OSA therapy really working for you? Is that CPAP really helping your OSA? What about if you are using an oral appliance? What about an implant?What about nasal strips?!In this episode, the STT Crew talk to Doug Kirsch, MD about the patient reported outcome tool recently released by the American Academy of Sleep Medicine (AASM).Dr Kirsch is with Atrium Health, based out of Charlotte, North Carolina is also a past president of the AASM. He was instrumental in getting a patient reported tool started and developed while he was at the AASM.He talks about the need for patient reported outcomes of OSA therapies. He talks about how we often use the adherence data from PAP machines, but what about other therapies? He also talks of those patients that may not use the “required” 4 hours of PAP therapies, but they feel better; so how do we measure those outcomes?Listen in as Dr Kirsch talks about PLATO, the Patient-reported Longitudinal Assessment Tool by the American Academy of Sleep Medicine.Catch the show on most podcast platforms or on YouTubehttps://youtu.be/Qo7CwSYVDOwA huge thanks to our sponsors:Medbridge Healthcare  : For Job Opportunities with MedBridge Healthcare visit: https://medbridgehealthcare.com/careers/Fisher & Paykel Healthcare  Discover how F&P full-face masks have led millions of people to a great night's sleep at https://www.fphcare.com/curiosityhttps://www.fphcare.com/us/homecare/sleep-apnea/React Health  https://www.reacthealth.com/More resources for clinicians can be found at Sleep Review Magazine  https://sleepreviewmag.com/Don't forget to Like, Share, Comment, and Subscribe!Learn more about the show at https://www.sleeptechtalk.com/thetechroomCredits:Audio/ Video: Diego R Mannikarote; Music: Pierce G MannikaroteHosts: J. Emerson Kerr, Robert Miller, Gerald George MannikaroteCopyright: ⓒ 2025 SleepTech Talk ProductionsEpisode 108The views and opinions expressed by guests on SleepTech Talk are their own and do not necessarily reflect those of the podcast hosts or SleepTech Talk as a whole. This podcast is intended for educational and informational purposes only and should not be considered medical advice. Listeners are encouraged to consult with a qualified healthcare professional for any medical concerns or questions.Sleep apnea, obstructive sleep apnea, oral sleep appliance, inspire, surgery, sleep surgery, CPAP, AI, Artificial Intelligence

Join Stephanie in a conversation with a team from Atrium Health's Capacity Command Center. They highlight a position being trialed - the Universal Acceptor Nurse. This role is helping gain efficiencies while allowing nurses to work at top of license.

Send us a textKatie Cushman, Simulation Operations Specialist at Atrium Health, shares her journey from nursing student to healthcare simulation professional and how finding her niche in simulation technology combines her passions for healthcare, education, and technology.• Transitioned from nursing school to pursuing a Bachelor's degree in Healthcare Simulation after realizing bedside nursing wasn't the right fit• Gained first meaningful exposure to simulation technology at a human-patient simulation day, seeing mannequins in action• Completed specialized education covering simulation foundations, education principles, operations, research and administration• Enjoys the technical aspects of working with simulation mannequins and problem-solving when technology challenges arise• Creates realistic simulations including organ procurement scenarios with Life Share and injury simulations for military training• Develops pipeline programs introducing middle and high school students to healthcare simulation as a career option• Recently earned CHSOS certification and aspires to eventually become a Certified Healthcare Simulation Educator and SSH Fellow• Values mentorship and connections within the simulation communityContact Katie Cushman at Kathryn.Cushman@advocatehealth.org or find her on LinkedIn to learn more about careers in healthcare simulation.Innovative SimSolutions.Your turnkey solution provider for medical simulation programs, sim centers & faculty design.

Send us a textThis week on *Earrings Off*, Lou and Teresa sit down with Dr. Burney to talk openly about menopause, the symptoms, the myths, and the opportunities for better health. Dr. Burney is a family physician in Charlotte, NC.  She completed her undergraduate education at Duke University and then attended Ohio State University for medical school.  Dr. Burney provides full service primary care for the medically underserved of all ages, from newborns to the elderly.  She joined the staff of Atrium Health after residency and served as the Medical Director for 8 years.  If you're navigating midlife or supporting someone who is, this conversation is for you. // LET'S CONNECT ON INSTAGRAM:-IG: https://www.instagram.com/theearringsoffpodcast/?next=%2F// S U B S C R I B ENew Podcasts and Blogs Every Weekhttps://www.earringsoff.com/subscribeYoutube | https://www.youtube.com/@earringsoffpodcast/videos// F O L L O W   Website | www.earringsoff.comFacebook |  Earrings OffLou and Teresa are thrilled to bring you their weekly podcast, where they dive deep into fascinating topics, interview experts, and share inspiring stories. But guess what? We need your support to keep this show going strong! Here's how you can help:Follow us and subscribe to our Youtube Channel at Earrings Off Podcast.Consider supporting the show with a one-time donation. Your contribution helps us enhance our content, upgrade our equipment, and deliver even more engaging episodes. To donate, simply click the “Support the show” link below. Every bit makes a difference—thank you!Like and Share: If you enjoy our podcast, hit that like button! It helps us reach more listeners. And don't forget to share your favorite episodes with friends and family. Word of mouth is powerful!Support the showSupport the show

Triangle-based Duke Health has crossed into the Piedmont region, expanding its footprint into Atrium Health and Novant Health territory. Duke acquired Lake Norman Regional in Mooresville in April and will rebrand the hospital as Duke Health Lake Norman. What will this mean for health care?

Charlotte FC wants to be more than a soccer club. In its annual Community Impact Report, the team highlights programs that serve kids, families, and neighborhoods across the Carolinas. In this episode, we hear from Trent Slagle, who helps shape the report; CC Schott, who leads community engagement; and Sarah Garrison from Atrium Health, a key partner. Together, they share how camps, clinics, mini-pitches, unified teams, and powerful personal stories are creating a legacy that goes beyond the pitch.Here is the report: https://www.charlottefootballclub.com/community/community-impact-report

Physician leadership is evolving from informal, "oldest doctor gets the job" to rigorous, accredited training programs that could reshape healthcare administration. Mike Sacopulos interviews Daniel A. Handel, MD, MBA, MPH, CPE, chief medical officer at Atrium Health, to discuss the basics of the new Healthcare Administration, Leadership, and Management (HALM) fellowship. The exam, first held in November 2024, will now be offered annually because of increased physician demand; it was previously biennial. Handel is the editor of the new textbook, Healthcare Administration, Leadership and Management: The Essentials, First Edition, with 44 expert contributors covering finance, compliance, HR, among other executive topics. He is also a contributor to a board review course that AAPL is developing for HALM. Handel's overarching advice for physician leaders: “Stay focused on your why — the purpose that drove you to leadership in the first place.” Resources: - Healthcare Administration, Leadership and Management: The Essentials, First Edition - Connect with Dan Handel, MD Learn more about the American Association for Physician Leadership at www.physicianleaders.org.

This episode is presented by Create A Video – Atrium Health told employees that it would no longer provide transgender medications or procedures due to federal guidance and state law. Activists are outraged. Also, research from Northwestern University shows how "performative virtue-signaling has become a threat to higher education." Subscribe to the podcast at: https://ThePetePod.com/ All the links to Pete's Prep are free: https://patreon.com/petekalinershow Media Bias Check: If you choose to subscribe, get 15% off here! Advertising and Booking inquiries: Pete@ThePeteKalinerShow.com Get exclusive content here!: https://thepetekalinershow.com/See omnystudio.com/listener for privacy information.

Welcome to FractureLine: the official weekly news feed from the Chest Wall Injury Society, where we will listen to all the bottom-line CWIS updates, shout-outs, fun facts, and weekly banter! This week, we are joined by the FL crew (SarahAnn, Dr. White, Dr. Bauman & Dr. Kaye). This week, we catch up with Dr. Sean Dieffenbaugher from Atrium Health in Charlotte, NC! We got a chance to hear his story of joining CWIS and what he has been able to accomplish over the last 5 years (and it is A LOT). There is some reflection from the Summit and talk regarding future directions for CWIS. This episode is the "fall-off-the-bone" type, perfectly seasoned and prepared! Come listen!

When something doesn't go as expected in our nursing care, how do we know if the standard of care was followed? Was generally acceptable practice used? This episode takes a deep dive into a nursing event peer review process in place at Atrium Health, part of Advocate Health.

Melissa Bridges, director of PA fellowships at Atrium Health and president of the Association of Post-graduate PA Programs (APPAP), chats with us (Bryan is president of APGAP, the Association of Post Graduate APRN programs) about PA/NP residencies/fellowships in critical care. Learn more at the Intensive Care Academy!

This episode features Dr. Frederick L. Greene, Emeritus Chair of Surgery at Carolinas Medical Center and Medical Director of Cancer Data Services at Atrium Health-Levine Cancer Institute. Dr. Greene shares insights on improving cancer registries, the evolution of surgical oncology, and the future impact of robotics and AI on healthcare.

This episode features Dr. Frederick L. Greene, Emeritus Chair of Surgery at Carolinas Medical Center and Medical Director of Cancer Data Services at Atrium Health-Levine Cancer Institute. Dr. Greene shares insights on improving cancer registries, the evolution of surgical oncology, and the future impact of robotics and AI on healthcare.

In Episode 18 of Constructing With Care, host Leslie Tullio welcomes back Sarah Francis (Enterprise AVP of Standards and Activation at Advocate Health), Jeff Schroder (AVP of Planning, Design & Construction at Atrium Health), and Sean Ashcroft (Healthcare Core Market Leader at DPR Construction). Together, they explore how prefabrication and standardization in healthcare environments drive cost certainty, boost efficiencies, reduce risk, and still allow for innovation. This episodes highlights:  The importance of robust pre‑construction collaboration: by bringing decision‑makers onboard sooner, teams can identify schedule savings and cost efficiencies early. How knowing handoffs between trades in advance enables reducing two weeks of work from scopes, enhancing efficiency on-site. The 80/20 rule: 80% standardized design ensures efficiency; 20% flexibility supports unique needs. How standardization frees time to focus on innovation—like implementing AI, new tools, and future‑proofed master planning. Why prefabrication enhances cost certainty, expedites schedules, elevates quality, and reduces risk. Tips to influence stakeholders, demonstrating community benefit, clinical engagement, proven partners, and breaking traditional paradigms.

Vince discusses Atrium Health's new Pearl District that is a part of the new Wake Forest Medical School campus. Also, Vince is joined by a guest who gives their view of Pride Month as a gay man.See omnystudio.com/listener for privacy information.

In Episode 17 of Constructing With Care, host Leslie Tullio welcomes back Sarah Francis (Enterprise AVP of Standards and Activation at Advocate Health), Jeff Schroeder (AVP of Planning, Design & Construction at Atrium Health), and Sean Ashcroft (Healthcare Core Market Leader at DPR Construction) for a deep dive into the impact of standardization in healthcare construction. Together, they explore how reducing variation across campuses not only enhances operational efficiency and construction outcomes but also significantly improves caregiver training and patient experience. The conversation highlights Advocate Health's journey toward adopting standardization, including lessons learned, the importance of collaboration, and the growing embrace of prefabrication in healthcare design and construction. Key Topics Covered: [00:01:00] Why standardization matters: benefits across efficiency, training, and care consistency [00:02:00] Lessons from Advocate Health's multi-year implementation journey [00:03:00] The importance of mindset, tenacity, and leadership in driving change [00:04:00] Creating collaborative spaces for innovation and shared ownership [00:06:00] How prefabrication evolves and improves over time [00:07:30] Gaining trade partner buy-in and building budget alignment [00:08:30] How standardization reduces labor risk and increases construction reliability [00:10:00] Advocating from within: Sarah Francis on internal evangelism and enterprise adoption [00:11:00] Clinical and operational benefits of standardization. Quotable Moments: Sarah Francis, Enterprise Assistant Vice President, Standards & Activation-Planning, Design & Construction, Advocate Health    "People are our greatest resource. What standardization does is ensure consistency, quality, and safety for our patients and teammates by reducing variability in their work environment."  Sean Ashcroft, Healthcare Core Market Leader, DPR Construction    "This is a continuous improvement journey—each project gets more efficient as stakeholders gain experience with prefabrication."  Jeff Schroder, AVP Planning, Design and Construction, Atrium Health, part of Advocate Health    "Revenue recognition improves because prefabrication helps us get projects out of the gate faster and execute more accurately." 

Britney Broyhill, DNP, ACNP-BC, FAANP, is the Senior Director of Advanced Practice for Atrium Health.Thanks for tuning in! Check out more episodes of The Well-Being Connector at www.bethejoy.org/podcast.

In this episode of The Best of LKN podcast, Jeff interviews Dr. Kenesha Kirkland and Dr. Christopher Messitt from Atrium Health Concierge Care in Cornelius. They discuss the innovative concierge care model, which allows for a more personalized and accessible healthcare experience. The conversation covers the inspiration behind the practice and the holistic approach to patient care that emphasizes prevention and individualized treatment plans. The doctors also share their excitement about expanding services to the Lake Norman area and the future of concierge care in the community.Atrium Health Concierge Care Lake Norman9623 Bailey Rd #220Cornelius, NC 28031(704) 801-8330---------------------------------------------------------------------------------------The Best of LKNhttps://thebestoflkn.com/Hosted by:Jeff HammReal Estate BrokerCharlotte & Lake Norman (NC)https://lknreal.com/Support the show

The average American family spends over $24,000 a year on healthcare, and costs continue to rise faster than inflation. Why can't we create a healthcare system that delivers more value for less money?In this conversation with Ann Somers Hogg, Director of Healthcare Research at the Clayton Christensen Institute, we explore the concept of "Zero Inflation Healthcare" and uncover why traditional health insurance models continue to drive costs up. Ann breaks down why many InsureTech startups initially struggled to disrupt incumbents and how a new approach to business model innovation could finally tame runaway healthcare costs.We cover:

In episode 16 of Constructing with Care, we dig into how prefabrication is driving tangible financial benefits, improving safety, and accelerating speed to market for healthcare construction projects. Industry leaders join the conversation to break down the power of standardization, long-term operational savings, and the importance of reducing variation in care environments. Hear real-world examples from healthcare systems and learn how cash flows and standardizing processes can support both the bottom line and community care. Guest: Sean Ashcroft, Healthcare Core Market Leader, DPR Construction   Guest: Jeff Schroder, AVP Planning, Design and Construction, Atrium Health, part of Advocate Health   Guest: Sarah Francis - Enterprise Assistant Vice President, Standards & Activation-Planning, Design & Construction, Advocate Health   Key Takeaways [5:20] – Setting the Stage: Financial Pressures + Tech Investments Host Leslie kicks off the conversation by exploring how prefab can address rising financial pressures for healthcare systems while supporting aggressive tech investments. [6:20] – Two Big Wins from Prefab (Sean) Sean highlights the long-term flexibility and operational uptime of prefab systems, plus how prefab impacts critical path scheduling to generate revenue faster. [7:12] – Hospital Perspective: Managing Cashflow at Scale (Jeff) Jeff dives into Atrium Health's approach to managing billions in active projects, explaining how prefab helps front-load purchases and reduce variation and risk from supply chain disruptions and tariffs. [9:17] – Standardization at the Enterprise Level (Sarah) Sarah underscores the importance of minimizing variation across builds, enabling process improvement and better data insights. Standardization is key to long-term efficiency. [10:12] – Compounding Effects of Eliminating Variation Sean expands on how standardization and prefab eliminate variation early—helping avoid rework and driving downstream time and cost savings.   Quotes Jeff Schroder, AVP Planning, Design and Construction, Atrium Health, part of Advocate Health   "Prefabrication helps us mitigate unpredictable factors like weather, labor shortages, and tariffs." Sarah Francis, Enterprise Assistant Vice President, Standards & Activation-Planning, Design & Construction, Advocate Health   "To ensure long-term efficiency we need to focus on minimizing variation, keeping a standardized approach that also allows us to measure and have data."  Sean Ashcroft, Healthcare Core Market Leader, DPR Construction   "There's a necessity for early engagement and ensuring the whole team understands the logic behind prefabrication to avoid gaps in execution."   

In this episode, Collin Lane, Senior Vice President of Ancillary, Shared Services, and Facilities Management at Atrium Health, discusses the transformative 1.1 million square foot advanced care facility at Atrium Health Carolinas Medical Center. Learn how this project addresses aging infrastructure, growing demand, and the future of healthcare delivery with innovative design, prefabrication, and cutting-edge technologies to meet the needs of a rapidly evolving market.

Accurate urine output monitoring is crucial for early detection and management of acute kidney injury. In this episode, Tom Calabro, Assistant Vice President of Cardiac Service Line for Atrium Health, discusses the importance of automated urine collection systems in today's fast-paced, data-driven healthcare environment, particularly concerning AKI. He explains AKI, its causes, and how it is categorized into pre-renal, intrinsic, and post-renal phases. Tom highlights the significance of urine output as an early indicator of AKI, emphasizing its role in timely intervention and improved patient outcomes, even amidst nursing shortages. He also shares his experience with the Akron automated urine collection system, praising its accuracy, EMR integration, ability to predict AKI onset up to 30 hours earlier, and overall contribution to enhanced patient care.  Tune in and learn how automated urine output monitoring can empower nurses, improve patient safety, and ultimately save lives! Resources: Connect with and follow Tom Calabro on LinkedIn. Follow Atrium Health on LinkedIn and explore their website.

Irene Bolis, Administrative Clinic Director for Outpatient Neurology at Atrium Health, discusses innovative recruitment strategies within the healthcare sector. She highlights how data-driven approaches are leveraged to identify top candidates, ensuring they align with Atrium Health's values and goals. Bolis also emphasizes the importance of nurturing employee growth through mentorship programs, fostering continuous learning and professional development. Her insights underscore a commitment to creating a supportive work environment that cultivates both talent acquisition and retention.

Four pharmacist entrepreneurs share their journeys from pharmacy to thriving businesses, offering tips, actionable advice and inspiration. This episode is brought to you by APhA. Summary In this engaging panel discussion, four pharmacist entrepreneurs—Brooke Griffin, Jimmy Pruitt III, Kelley Carlstrom, and Natalie Park—share their unique paths from pharmacy to thriving businesses. Discover how they built their ventures, made strategic decisions, and overcame challenges along the way. Gain practical insights into audience building, pricing strategies, navigating sales, and balancing personal and professional growth.  Whether you're dreaming up a new idea or ready to expand your business, this episode is packed with actionable advice and inspiration to help you take the next step in your entrepreneurial journey. About Today's Guests Kelley Carlstrom is the CEO and founder of KelleyCPharmD, an education company that fills the considerable gap in clinical oncology training. She is passionate about democratizing oncology pharmacy education and increasing accessibility and inclusion through her unique L.E.A.R.N Oncology Method. Brooke Griffin is a pharmacist, professor, keynote speaker, and professional coach. She offers group and 1:1 coaching for pharmacists who are feeling stuck and want clarity on their next steps. She hosts a motivational 5-minute podcast, Today's Bold Idea, and is on this self-discovery journey alongside all of you. She believes everyone deserves a coach! Dr. Natalie Park is a co-founder and CEO of Pharmesol, an AI pharmacy assistant that automates inbound/outbound calls, messages, and associated workflows such as documentation to save the pharmacy teams time, streamlines operations, and gives 24/7 concierge-like experience for their customers. She is a pharmacist with a passion for leveraging technology and innovation in the pharmacy industry. Jimmy Pruitt III, PharmD, BCPS, BCCCP, BCEMP, a pharmacist and entrepreneur, earned his Doctor of Pharmacy degree from Presbyterian College and completed residencies at Florida Hospital Orlando and Grady Health System. He founded EMPowerRX Conference and Pharmacy & Acute Care University (PACU) to innovate healthcare education and inspire pharmacists to pursue entrepreneurship. In 2021, he received the Excellence in Diversity award and was named Alumni of the Year at Presbyterian College. Dr. Pruitt is also an Emergency Medicine Clinical Pharmacy Specialist at Atrium Health and hosts the "Pharm So Hard" podcast, aiming to educate and elevate the pharmacy profession. Mentioned on the Show Start by Jon Acuff Brooke Griffin on LinkedIn Kelley Carlstrom on LinkedIn Natalie Park on LinkedIn Jimmy Pruitt III on LinkedIn YFP Disclaimer Subscribe to the YFP Newsletter Tim Ulbrich on LinkedIn YFP on Instagram YFP Facebook Group  

 Monday, December 16th, 2024Today, more corporate media including ABC and Jeff Bezos are capitulating to Donald Trump's administration; a Coast Guard commander miscarried and nearly died after being denied care; Atrium Health has canceled medical debt for nearly 11,500 people after an NBC report; a Trump crypto venture partner has links to Iran and Hezbollah; an incoming West Virginia lawmaker has been charged with threatening to kill fellow lawmakers; Senate Democrats are demanding communications between Boris Epshteyn and potential Trump appointees; the missing American Travis Timmerman has been found in Syria; the Air Force has named the first female SERE specialist as chief master sergeant; Manchin and Sinema hate working class Americans; and Allison and Dana deliver your Good News.Thank You Helix SleepBig shoutout today to Helix Sleep. Helix is offering 20% off sitewide plus 2 FREE  Pillows with any mattress purchase when you go to HelixSleep.com/DailyBeans.Stories:North Carolina hospital company forgives debts of 11,500 people after NBC News report (NBC News)Missing American Travis Timmerman found in Syria is released to U.S. forces, officials say (Erik Ortiz and Mosheh Gains  | NBC News)ABC agrees to give $15 million to Donald Trump's presidential library to settle defamation lawsuit (Michael R. Sisak | AP News)Senate Democrats want communications between Boris Epshteyn and potential Trump appointees disclosed (Daniel Klaidman | CBS News)Trump crypto venture partners with platform linked to Middle East militants (Alexandra Ulmer and Simon Lewis | Reuters)Air Force names first female SERE specialist as chief master sergeant (airforcetimes)Have some good news; a confession; or a correction to share?Good News & Confessions - The Daily Beanshttps://www.dailybeanspod.com/confessional/From The Good NewsPictures of Belonging: Miki Hayakawa, Hisako Hibi, and Miné Okubo (americanart.si.edu)usda.govOffice of Weights and Measures (OWM) (use.gov)NASA.govThe Bureau of Engraving & PrintingNational Archives (archives.gov)USGS.gov Check out other MSW Media podcastshttps://mswmedia.com/shows/Subscribe for free to MuellerSheWrote on Substackhttps://muellershewrote.substack.comFollow AG and Dana on Social MediaDr. Allison Gill Substack|Muellershewrote, Twitter|@MuellerSheWrote, Threads|@muellershewrote, TikTok|@muellershewrote, IG|muellershewrote, BlueSky|@muellershewroteDana GoldbergTwitter|@DGComedy, IG|dgcomedy, facebook|dgcomedy, IG|dgcomedy, danagoldberg.com, BlueSky|@dgcomedyHave some good news; a confession; or a correction to share?Good News & Confessions - The Daily Beanshttps://www.dailybeanspod.com/confessional/ Listener Survey:http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=shortFollow the Podcast on Apple:The Daily Beans on Apple PodcastsWant to support the show and get it ad-free and early?Supercasthttps://dailybeans.supercast.com/Patreon https://patreon.com/thedailybeansOr subscribe on Apple Podcasts with our affiliate linkThe Daily Beans on Apple Podcasts

Researchers uncover a critical Windows zero-day.  An alleged Ukrainian cyberattack targets one of Russia's largest banks. Russian group BlueAlpha exploits CloudFlare services. Microsoft flags Chinese hacking group Storm-0227 for targeting critical infrastructure and U.S. government agencies. SonicWall patches high-severity vulnerabilities in its secure access gateway. Atrium Health reports a data breach affecting over half a million individuals. Rockwell Automation discloses four critical vulnerabilities in its Arena software. U.S. authorities arrest an alleged member of the Scattered Spider gang. Our guest is Hugh Thompson, RSAC program committee chair, discussing the 2025 Innovation Sandbox Contest and its new investment component. C3PO gets caught in the crypto mines.  Remember to leave us a 5-star rating and review in your favorite podcast app. Miss an episode? Sign-up for our daily intelligence roundup, Daily Briefing, and you'll never miss a beat. And be sure to follow CyberWire Daily on LinkedIn. CyberWire Guest Joining Dave today is Hugh Thompson, RSAC program committee chair, discussing the 2025 Innovation Sandbox Contest and its new investment component. Read more details in the press release.  Selected Reading New Windows 7 To 11 Warning As Zero-Day With No Official Fix Confirmed (Forbes) Russian users report Gazprombank outages amid alleged Ukrainian cyberattack (The Record) BlueAlpha Russian hackers caught abusing CloudFlare services (SC Media) U.S. org suffered four month intrusion by Chinese hackers (Bleeping Computer) Microsoft: Another Chinese cyberspy crew targeting US critical orgs 'as of yesterday' (The Register) SonicWall Patches 6 Vulnerabilities in Secure Access Gateway (SecurityWeek) Mitel MiCollab zero-day and PoC exploit unveiled (Help Net Security) Atrium Health Data Breach Impacts 585,000 People (SecurityWeek) Rockwell Automation Vulnerabilities Let Attackers Execute Remote Code (Cyber Security News) US arrests Scattered Spider suspect linked to telecom hacks  (Bleeping Computer) Nebraska Man pleads guilty to $3.5 million cryptojacking scheme (Bleeping Computer) Share your feedback. We want to ensure that you are getting the most out of the podcast. Please take a few minutes to share your thoughts with us by completing our brief listener survey as we continually work to improve the show.  Want to hear your company in the show? You too can reach the most influential leaders and operators in the industry. Here's our media kit. Contact us at cyberwire@n2k.com to request more info. The CyberWire is a production of N2K Networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

A Gaston County judge on Monday ordered that Joshua Hunsucker, a former paramedic from North Carolina, remain behind bars without bond after prosecutors described him as a danger to his children and in-laws. Hunsucker is accused of using tetrahydrozoline, a toxic chemical found in Visine eye drops, to murder his wife, 32-year-old Stacy Hunsucker, in 2018 and to poison their 10-year-old daughter in 2023. Prosecutors allege that Hunsucker attempted to implicate his wife's parents, John and Suzie Robinson, in both incidents. The Robinsons, who were present in court, had filed a motion in August requesting the revocation of Hunsucker's bond, citing concerns over alleged harassment and intimidation. They claim Hunsucker has been following them, harassing them, and attempting to remove them from their grandchildren's lives. Initially, the death of Stacy Hunsucker was attributed to natural causes due to reported heart issues. However, suspicions arose when it was revealed that her husband had requested no autopsy and a swift cremation. As an organ donor, tests on her organs and blood later detected the presence of tetrahydrozoline, leading to murder charges against Hunsucker in December 2019. He had been released on a $1.5 million bond at that time. In 2023, Hunsucker reported to the Mount Holly Police Department that John Robinson had attacked and kidnapped him. According to the police report, Hunsucker claimed he was pistol-whipped, zip-tied, and injected with an unknown substance. Authorities have found no evidence supporting these allegations. Prosecutors argue that Hunsucker fabricated the incident to frame the Robinsons and divert attention from his own actions. In addition to first-degree murder and insurance fraud charges related to his wife's death, Hunsucker now faces new charges connected to his daughter's alleged poisoning and the harassment of his in-laws. These include four counts of intimidation of a witness and four counts of obstruction of justice. While he was granted a $25,000 bond for these new charges, the judge noted that he would remain in custody due to the severity of the allegations and the revocation of his previous bond. "The poisoning of his daughter was once again done with an attempt to implicate Mr. and Mrs. Robinson in the death of his wife and remove the Robinsons from the lives of his daughters," the motion to revoke Hunsucker's bond stated. The Robinsons have expressed relief at the court's decision to keep Hunsucker detained, emphasizing their concerns for their safety and the well-being of their grandchildren. The case remains ongoing as prosecutors continue to build their case against Hunsucker.  AND! WHILE OUT ON BOND FOR HIS WIFE'S MURDER…. Hunsucker, charged with fatally poisoning his wife with eye drops in 2018, pleaded not guilty to felony arson on for allegedly setting a medical helicopter on fire. Joshua Hunsucker, accused of igniting a syringe pump mid-flight on November 26, 2019, forced the Atrium Health helicopter to make an emergency landing at a car dealership on Independence Boulevard in Charlotte. Hunsucker was charged with felony property damage to Atrium Health, posting bond shortly after his arrest. At the time, he was already out on bond awaiting trial for the alleged murder of his wife, Stacy Robinson Hunsucker. Just weeks after the helicopter incident, he was taken back into custody and formally charged with her murder. Want to listen to ALL of our podcasts AD-FREE? Subscribe through APPLE PODCASTS, and try it for three days free: https://tinyurl.com/ycw626tj Follow Our Other Cases: https://www.truecrimetodaypod.com The latest on The Downfall of Diddy, The Trial of Karen Read, The Murder Of Maddie Soto, Catching the Long Island Serial Killer, Awaiting Admission: BTK's Unconfessed Crimes, Delphi Murders: Inside the Crime, Chad & Lori Daybell, The Murder of Ana Walshe, Alex Murdaugh, Bryan Kohberger, Lucy Letby, Kouri Richins, Malevolent Mormon Mommys, The Menendez Brothers: Quest For Justice, The Murder of Stephen Smith, The Murder of Madeline Kingsbury, The Murder Of Sandra Birchmore, and much more! Listen at https://www.truecrimetodaypod.com

A Gaston County judge on Monday ordered that Joshua Hunsucker, a former paramedic from North Carolina, remain behind bars without bond after prosecutors described him as a danger to his children and in-laws. Hunsucker is accused of using tetrahydrozoline, a toxic chemical found in Visine eye drops, to murder his wife, 32-year-old Stacy Hunsucker, in 2018 and to poison their 10-year-old daughter in 2023. Prosecutors allege that Hunsucker attempted to implicate his wife's parents, John and Suzie Robinson, in both incidents. The Robinsons, who were present in court, had filed a motion in August requesting the revocation of Hunsucker's bond, citing concerns over alleged harassment and intimidation. They claim Hunsucker has been following them, harassing them, and attempting to remove them from their grandchildren's lives. Initially, the death of Stacy Hunsucker was attributed to natural causes due to reported heart issues. However, suspicions arose when it was revealed that her husband had requested no autopsy and a swift cremation. As an organ donor, tests on her organs and blood later detected the presence of tetrahydrozoline, leading to murder charges against Hunsucker in December 2019. He had been released on a $1.5 million bond at that time. In 2023, Hunsucker reported to the Mount Holly Police Department that John Robinson had attacked and kidnapped him. According to the police report, Hunsucker claimed he was pistol-whipped, zip-tied, and injected with an unknown substance. Authorities have found no evidence supporting these allegations. Prosecutors argue that Hunsucker fabricated the incident to frame the Robinsons and divert attention from his own actions. In addition to first-degree murder and insurance fraud charges related to his wife's death, Hunsucker now faces new charges connected to his daughter's alleged poisoning and the harassment of his in-laws. These include four counts of intimidation of a witness and four counts of obstruction of justice. While he was granted a $25,000 bond for these new charges, the judge noted that he would remain in custody due to the severity of the allegations and the revocation of his previous bond. "The poisoning of his daughter was once again done with an attempt to implicate Mr. and Mrs. Robinson in the death of his wife and remove the Robinsons from the lives of his daughters," the motion to revoke Hunsucker's bond stated. The Robinsons have expressed relief at the court's decision to keep Hunsucker detained, emphasizing their concerns for their safety and the well-being of their grandchildren. The case remains ongoing as prosecutors continue to build their case against Hunsucker.  AND! WHILE OUT ON BOND FOR HIS WIFE'S MURDER…. Hunsucker, charged with fatally poisoning his wife with eye drops in 2018, pleaded not guilty to felony arson on for allegedly setting a medical helicopter on fire. Joshua Hunsucker, accused of igniting a syringe pump mid-flight on November 26, 2019, forced the Atrium Health helicopter to make an emergency landing at a car dealership on Independence Boulevard in Charlotte. Hunsucker was charged with felony property damage to Atrium Health, posting bond shortly after his arrest. At the time, he was already out on bond awaiting trial for the alleged murder of his wife, Stacy Robinson Hunsucker. Just weeks after the helicopter incident, he was taken back into custody and formally charged with her murder. Want to listen to ALL of our podcasts AD-FREE? Subscribe through APPLE PODCASTS, and try it for three days free: https://tinyurl.com/ycw626tj Follow Our Other Cases: https://www.truecrimetodaypod.com The latest on The Downfall of Diddy, The Trial of Karen Read, The Murder Of Maddie Soto, Catching the Long Island Serial Killer, Awaiting Admission: BTK's Unconfessed Crimes, Delphi Murders: Inside the Crime, Chad & Lori Daybell, The Murder of Ana Walshe, Alex Murdaugh, Bryan Kohberger, Lucy Letby, Kouri Richins, Malevolent Mormon Mommys, The Menendez Brothers: Quest For Justice, The Murder of Stephen Smith, The Murder of Madeline Kingsbury, The Murder Of Sandra Birchmore, and much more! Listen at https://www.truecrimetodaypod.com